Prone 18F-FDG PET/CT changes diagnostic and surgical intervention in a breast cancer patient: some considerations about PET/CT imaging acquisition protocol

2015 ◽  
Vol 39 (3) ◽  
pp. 506-509 ◽  
Author(s):  
Carla Canevari ◽  
Francesca Gallivanone ◽  
Veronica Zuber ◽  
Alberto Marassi ◽  
Claudio Losio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patient ◽  
Breast Cancer Patient ◽  
Fdg Pet ◽  
Surgical Intervention ◽  
Ct Imaging ◽  
Acquisition Protocol ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

Indeterminate pulmonary nodules on CT images in breast cancer patient: The additional value of 18F-FDG PET/CT

2012 ◽  
Vol 56 (4) ◽  
pp. 417-424 ◽  
Author(s):  
Laura Evangelista ◽  
Annalori Panunzio ◽  
Anna Rita Cervino ◽  
Lorenzo Vinante ◽  
Adil Al-Nahhas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patient ◽  
Breast Cancer Patient ◽  
Fdg Pet ◽  
Pulmonary Nodules ◽  
Ct Images ◽  
Pet Ct ◽  
18F Fdg ◽  
Additional Value ◽  
Fdg Pet Ct

scholarly journals [18F]-FDG PET/CT of the Pulmonary Benign Metastasizing Leiomyoma in a Breast Cancer Patient: A Case Report

Surgeries ◽  
2021 ◽  
Vol 2 (3) ◽  
pp. 231-236
Author(s):  
Chun-Hao Kao ◽  
Hong-Wei Gao ◽  
Kai-Hsiung Ko ◽  
Guo-Shiou Liao ◽  
Chi-Jung Tsai
Keyword(s):  
Breast Cancer ◽  
Cancer Patient ◽  
Breast Cancer Patient ◽  
Lung Metastasis ◽  
Fdg Pet ◽  
Benign Metastasizing Leiomyoma ◽  
Pet Ct ◽  
Metastasizing Leiomyoma ◽  
18F Fdg ◽  
Fdg Pet Ct

18F-fluorodeoxyglucose ([18F]-FDG) positron emission tomography/computed tomography (PET/CT) is a useful functional image technique to evaluate the disease extent in many cancers, as well as differentiate benign disease from malignant metastasis. We report the case of a 49-year-old woman with breast cancer and suspected lung metastasis by conventional images. After FDG-PET/CT demonstrating faint, or even no FDG uptake in bilateral pulmonary nodules, accompanied with obvious uterine fibroids, benign metastasizing leiomyoma (BML) of the lung was included in a differential diagnosis and finally confirmed by surgical pathology. FDG PET/CT showed its value in the diagnosis of BML in the breast cancer patient who was misleading as lung metastasis during outpatient follow-up.

Effect of 18F-FDG PET/CT Imaging in Patients With Clinical Stage II and III Breast Cancer

2008 ◽  
Vol 71 (3) ◽  
pp. 695-704 ◽  
Author(s):  
David Groheux ◽  
Jean-Luc Moretti ◽  
Georges Baillet ◽  
Marc Espie ◽  
Sylvie Giacchetti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Fdg Pet ◽  
Clinical Stage ◽  
Ct Imaging ◽  
Stage Ii ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

scholarly journals Bone Marrow Metastasis Is an Early Stage of Bone Metastasis in Breast Cancer Detected Clinically by F18-FDG-PET/CT Imaging

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Kusai M. Al-Muqbel
Keyword(s):  
Breast Cancer ◽  
Bone Marrow ◽  
Bone Metastasis ◽  
Bone Metastases ◽  
Fdg Pet ◽  
Early Stage ◽  
Ct Imaging ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

Objective. To determine the value of 18F-FDG PET/CT in detection of bone marrow (BM) metastasis in breast cancer which is considered an early stage of bone metastasis. Patients and Methods. Retrospectively, breast cancer patients with bone metastasis were included. BM metastasis was considered if the lesion was PET positive/CT occult while bone metastasis was considered if the lesion was PET positive/ CT positive. BM metastases were observed sequentially on F18-FDG PET/CT. Results. We included 35 patients. Eighteen patients (51%) had BM metastases in addition to other bone metastases. BM metastases comprised 24% of all lesions. Posttreatment scan was performed on 26/35 patients. Twenty-three percent of BM metastases had resolved completely without causing bone destruction after treatment. Sixty-five percent of BM metastases had converted into bone metastases after treatment. Twelve percent of BM metastases had persisted after treatment. Conclusion. This retrospective study showed clinically by 18F-FDG PET/CT imaging that BM metastasis is an early stage of bone metastasis in breast cancer. Interestingly, 18F-FDG-PET/CT showed that early eradication of individual BM metastasis by systemic treatment precluded development of bone metastasis. However, more research is needed to study the impact of an early diagnosis of BM metastases on treatment outcome.

Sign in / Sign up

Export Citation Format

Share Document